Have French recommendations had an impact on the treatment and survival of middle and lower rectal cancer patients?

Hill, 2003, Fréquence des cancers en France, Bull Cancer, 93, 207 Faivre, 2004, Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study, Gastroenterology, 126, 1674, 10.1053/j.gastro.2004.02.018 Gunderson, 2004, Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis, J Clin Oncol, 22, 1785, 10.1200/JCO.2004.08.173 Borie, 2008, Impact of French consensus guidelines on the management of colonic and rectal cancer: population-based studies, J Chir, 145, 247, 10.1016/S0021-7697(08)73754-2 1994 Hermanek, 2000, Role of the surgeon as a variable in the treatment of rectal cancer, Semin Surg Oncol, 19, 329, 10.1002/ssu.3 Hall, 1998, Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent: predictor of survival but not local recurrence?, Dis Colon Rectum, 41, 979, 10.1007/BF02237384 Wibe, 2002, Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer, Br J Surg, 89, 327, 10.1046/j.0007-1323.2001.02024.x Finn-Faivre, 1999, Evidence of improving survival of patients with rectal cancer in France: a population-based study, Gut, 44, 377, 10.1136/gut.44.3.377 Launoy, 1996, Interêt des registres de cancer dans l’évaluation de la prise en charge des cancers colorectaux, Rev Epidemiol Sante Publique, 44, S22 Phelip, 2004, Regional variations in management of rectal cancer in France, Gastroenterol Clin Biol, 28, 378, 10.1016/S0399-8320(04)94939-1 Maurel, 1998, Prise en charge thérapeutique du cancer colique en France, Gastroenterol Chim Biol, 22, 590 Bouvier, 2004, Changing practices for diagnosis and treatment of colorctal cancer in Calvados: 1990–1999, Gastroenteral Clin Biol, 24, 371 1999, Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer, J Clin oncol, 17, 1356, 10.1200/JCO.1999.17.5.1356 Gatta, 2000, Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study, Gut, 47, 533, 10.1136/gut.47.4.533 Faivre-Finn, 2002, Colon cancer in France: evidence for improvement in management and survival, Gut, 51, 60, 10.1136/gut.51.1.60 Glattli, 1995, Is there still a place for abdominoperineal resection of the rectum?, Eur J Surg Oncol, 21, 11, 10.1016/S0748-7983(05)80060-5 Sprangers, 1995, Quality of life in colorectal cancer. Stoma vs. non-stoma patients, Dis Colon Rectum, 38, 361, 10.1007/BF02054222 Bokey, 1997, Factors affecting survival after excision of the rectum for cancer: a multivariate analysis, Dis Colon Rectum, 40, 3, 10.1007/BF02055674 Bokey, 1999, Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection, Br J Surg, 86, 1164, 10.1046/j.1365-2168.1999.01216.x Monges, 1998, Recommendations for pathologic reporting of resected colonic neoplasms, Gastroenterol Clin Biol, 22, S126 Trétarre, 2005, Management and prognosis of colon cancer in patients with intestinal obstruction or peritonitis: a French population-based study, Med Sci Monit, 11, CR266 1995, Efficacy of adjuvant fluorouracil and folinic acid in colon cancer, Lancet, 345, 939, 10.1016/S0140-6736(95)90696-7 2007, Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study, Lancet, 370, 2020, 10.1016/S0140-6736(07)61866-2 Bujko, 2008, Adjuvant chemotherapy for rectal cancer, Lancet, 371, 1502, 10.1016/S0140-6736(08)60650-9